Galanin: structural requirements for binding and signal transduction in RINm5F insulinoma cells
- PMID: 1699538
- DOI: 10.1016/s0006-291x(05)80204-9
Galanin: structural requirements for binding and signal transduction in RINm5F insulinoma cells
Abstract
Receptors for galanin, a neuropeptide inhibiting insulin release, have been described on RINm5F insulinoma cells. To characterize structural requirements for binding and biological activity of galanin, we studied binding and inhibition of hormone stimulated intracellular cAMP-production of N-terminal galanin fragments and -analogues in RINm5F cells. Half-maximal binding and potency were the same for all peptides used. Active peptides had the following rank of potency: galanin = galanin(1-22(23)Cys) greater than galanin(1-29(4)NLe) greater than galanin(1-18) greater than galanin(1-29(7)DAla) greater than galanin(1-29(2)DTrp4NLe7DAla) greater than galanin(1-29(2)DTrp). Galanin(3-29) was inactive. Therefore the first two amino acids of the galanin molecule with the indole side chain of the tryptophane residue in the right steric position are crucial for receptor binding.
Similar articles
-
Inhibition of adenylate cyclase activity by galanin in rat insulinoma cells is mediated by the G-protein Gi3.Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):369-75. doi: 10.1042/bj3030369. Biochem J. 1994. PMID: 7526840 Free PMC article.
-
Structural requirements for galanin interaction with receptors from pancreatic beta cells and from brain tissue of the rat.Peptides. 1989 Jul-Aug;10(4):757-61. doi: 10.1016/0196-9781(89)90109-5. Peptides. 1989. PMID: 2479930
-
Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.Proc Natl Acad Sci U S A. 1993 May 1;90(9):4231-5. doi: 10.1073/pnas.90.9.4231. Proc Natl Acad Sci U S A. 1993. PMID: 7683428 Free PMC article.
-
[Structure-function studies of galanin].Nihon Naibunpi Gakkai Zasshi. 1992 Jul 20;68(7):637-57. doi: 10.1507/endocrine1927.68.7_637. Nihon Naibunpi Gakkai Zasshi. 1992. PMID: 1381324 Review. Japanese.
-
Galanin and galanin antagonists: molecular and biochemical perspectives.Trends Pharmacol Sci. 1992 Aug;13(8):312-7. doi: 10.1016/0165-6147(92)90098-q. Trends Pharmacol Sci. 1992. PMID: 1384214 Review.
Cited by
-
Galanin in an Agnathan: Precursor Identification and Localisation of Expression in the Brain of the Sea Lamprey Petromyzon marinus.Front Neuroanat. 2019 Sep 13;13:83. doi: 10.3389/fnana.2019.00083. eCollection 2019. Front Neuroanat. 2019. PMID: 31572131 Free PMC article.
-
Galanin and the regulation of islet hormone secretion.Int J Pancreatol. 1992 Jun;11(3):147-60. doi: 10.1007/BF02924180. Int J Pancreatol. 1992. PMID: 1381407 Review. No abstract available.
-
Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide.Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11435-9. doi: 10.1073/pnas.88.24.11435. Proc Natl Acad Sci U S A. 1991. PMID: 1722333 Free PMC article.
-
Galanin--a neuropeptide with inhibitory actions.Cell Mol Neurobiol. 1995 Dec;15(6):653-73. doi: 10.1007/BF02071130. Cell Mol Neurobiol. 1995. PMID: 8719035 Free PMC article. Review.
-
The Galaninergic System: A Target for Cancer Treatment.Cancers (Basel). 2022 Aug 1;14(15):3755. doi: 10.3390/cancers14153755. Cancers (Basel). 2022. PMID: 35954419 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources